Outset Medical, Inc.
OM
$4.56
$0.122.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.16% | 46.19% | 35.45% | 33.58% | 39.50% |
| Total Depreciation and Amortization | -27.32% | -21.48% | -11.37% | -2.77% | -5.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.79% | -54.10% | 42.00% | -35.20% | -34.72% |
| Change in Net Operating Assets | 1,553.38% | 161.01% | 18.65% | -47.60% | -145.10% |
| Cash from Operations | 69.27% | 85.53% | 44.10% | 32.54% | 39.50% |
| Capital Expenditure | 59.49% | -143.33% | 65.25% | 95.92% | 49.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80.78% | -179.03% | -32.86% | 342.01% | -46.81% |
| Cash from Investing | -81.31% | -180.02% | -32.27% | 361.70% | -46.74% |
| Total Debt Issued | -- | -- | 47.72% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 90.91% | -100.00% | -80.44% | -100.00% | -97.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.91% | -598.70% | -18.88% | -102.82% | -97.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.71% | -739.96% | -32.35% | 181.66% | -4,924.18% |